연구동향 분석

Quantification of Human Plasma-Busulfan Concentration by Liquid Chromatography-Tandem Mass Spectrometry

문수영 임민규 홍수지 한민제 송상훈 임경수 유경상 장인진 이지원 강형진 송정한 전용범 2014년

논문상세정보
인용/피인용
' Quantification of Human Plasma-Busulfan Concentration by Liquid Chromatography-Tandem Mass Spectrometry' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • busulfan
  • drug monitoring
  • hematopoietic stem cell transplantation
  • liquidchromatography
  • tandem mass spectrometry
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,623 0

0.0%

' Quantification of Human Plasma-Busulfan Concentration by Liquid Chromatography-Tandem Mass Spectrometry' 의 참고문헌

  • Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients
    Carreras E Biol Blood Marrow Transplant 13 1448-1454 [2007]
  • Therapeutic drug monitoring of busulfan in transplantation
    Russell JA Curr Pharm Des 14 1936-1949 [2008]
  • Tandem mass spectrometry method for the quantification of serum busulfan
    Kellogg MD Ther Drug Monit 27 625-629 [2005]
  • Superior survival after replacing oral with intravenous busulfan in autologous stem cell transplantation for non-Hodgkin lymphoma with busulfan, cyclophosphamide and etoposide
    Dean RM Br J Haematol 148 226-234 [2010]
  • Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS
    Matuszewski BK Anal Chem 75 3019-3030 [2003]
  • Sensitive and rapid quantification of busulfan in small plasma volumes by liquid chromatography-electrospray mass spectrometry
    Mürdter TE Clin Chem 47 1437-1442 [2001]
  • Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 children
    Méresse V Bone Marrow Transplant 10 135-141 [1992]
  • Rapid and sensitive high-performance liquid chromatographic method for busulfan assay in plasma
    Bleyzac N J Chromatogr B Biomed Sci Appl 742 427-432 [2000]
  • Quantification of busulfan in plasma using liquid chromatography electrospray tandem mass spectrometry (HPLC-ESI-MS/MS)
    Snyder ML Methods Mol Biol 603 129-136 [2010]
  • Quantification of busulfan in plasma by liquid chromatography-ion spray mass spectrometry. Application to pharmacokinetic studies in children
    Quernin MH J Chromatogr B Biomed Sci Appl 763 61-69 [2001]
  • Quantification of busulfan in plasma by gas chromatography-mass spectrometry following derivatization with tetrafluorothiophenol
    Quernin MH J Chromatogr B Biomed Sci Appl 709 47-56 [1998]
  • Q2B: validation of analytical procedures: methodology
    International Conference on Harmonization US FDA Federal Register 62 27463-27467 [1997]
  • Pharmacokinetic behavior and appraisal of intravenous busulfan dosing in infants and older children: the results of a population pharmacokinetic study from a large pediatric cohort undergoing hematopoietic stem-cell transplantation
    Paci A Ther Drug Monit 34 198-208 [2012]
  • Novel pharmacokinetic behavior of intravenous busulfan in children with thalassemia undergoing hematopoietic stem cell transplantation: a prospective evaluation of pharmacokinetic and pharmacodynamic profile with therapeutic drug monitoring
    Gaziev J Blood 115 4597-4604 [2010]
  • Monitoring of N,N-dimethylacetamide in children during i.v.-busulfan therapy by liquid chromatography-mass spectrometry
    Oechtering D J Chromatogr B Analyt Technol Biomed Life Sci 838 129-134 [2006]
  • Metabolism of the cysteine S-conjugate of busulfan involves a beta-lyase reaction
    Cooper AJ Drug Metab Dispos 36 1546-1552 [2008]
  • Highly variable pharmacokinetics of once-daily intravenous busulfan when combined with fludarabine in pediatric patients: phase I clinical study for determination of optimal once-daily busulfan dose using pharmacokinetic modeling
    Lee JW Biol Blood Marrow Transplant 18 944-950 [2012]
  • Elecsys Hepatitis B Surface Antigen Quantitative Assay: Performance Evaluation and Correlation with Hepatitis B Virus DNA during 96 Weeks of Follow-up in Chronic Hepatitis B Patients
    이현지 Annals of Laboratory Medicine 32 6 420-425 [2012]
  • Development of a rapid and specific assay for detection of busulfan in human plasma by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry
    dos Reis EO Rapid Commun Mass Spectrom 19 1666-1674 [2005]
  • Determination of busulfan in human plasma using high-performance liquid chromatography with pre-column derivatization and fluorescence detection
    Peris JE J Chromatogr B Biomed Sci Appl 730 33-40 [1999]
  • Determination of busulfan in human plasma using an ELISA format
    Courtney JB Ther Drug Monit 31 489-494 [2009]
  • Determination of busulfan in human plasma by gas chromatography with electron-capture detection
    Chen TL J Chromatogr 425 303-309 [1988]
  • Cytotoxicity of dimethylacetamide and pharmacokinetics in children receiving intravenous busulfan
    Hempel G J Clin Oncol 25 1772-1778 [2007]
  • Busulphan in blood and marrow transplantation: dose, route, frequency and role of therapeutic drug monitoring
    Nath CE Curr Clin Pharmacol 2 75-91 [2007]
  • Busulfan in hematopoietic stem cell transplantation
    Ciurea SO Biol Blood Marrow Transplant 15 523-536 [2009]
  • A simplified method for busulfan monitoring using dried blood spot in combination with liquid chromatography/tandem mass spectrometry
    Ansari M Rapid Commun Mass Spectrom 26 1437-1446 [2012]
  • A novel method for quantification of sulfolane (a metabolite of busulfan) in plasma by gas chromatography-tandem mass spectrometry
    Versace F Anal Bioanal Chem 404 1831-1838 [2012]
  • A fast and simple assay for busulfan in serum or plasma by liquid chromatography-tandem mass spectrometry using turbulent flow online extraction technology
    Bunch DR J Chromatogr B Analyt Technol Biomed Life Sci 878 3255-3258 [2010]